Irlandia - angielski - HPRA (Health Products Regulatory Authority)

merit pharmaceuticals limited - tiotropium bromide - inhalation powder, hard capsule - 18 microgram(s) - anticholinergics; tiotropium bromide

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd., t/a gerard laboratories - tiotropium - inhalation powder, hard capsule - 18 microgram(s) - tiotropium bromide

Malta - angielski - Medicines Authority

mylan ireland limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - tiotropium bromide - inhalation powder hard capsule - tiotropium bromide 18 µg - drugs for obstructive airway diseases

Malta - angielski - Medicines Authority

viatris limited damastown industrial park, mulhuddart, dublin 15, dublin, ireland - inhalation powder hard capsule - tiotropium bromide 18 µg - drugs for obstructive airway diseases

Unia Europejska - angielski - myHealthbox

forest laboratories uk ltd - colistimethate sodium - inhalation powder, hard capsule - each capsule contains 1662500iu (approximately equal to 125mg) of colistimethate sodium - cystic fibrosis - antibacterials for systemic use - colobreathe is indicated for the management of chronic pulmonary infections due to pseudomonas aeruginosa in patients with cystic fibrosis (cf) aged 6 years and older

Unia Europejska - angielski - EMA (European Medicines Agency)

teva b.v. - colistimethate sodium - cystic fibrosis - antibacterials for systemic use, - colobreathe is indicated for the management of chronic pulmonary infections due to pseudomonas aeruginosa in patients with cystic fibrosis (cf) aged six years and older.consideration should be given to official guidance on the appropriate use of antibacterial agents.

Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

lfb biopharmaceuticals ltd - human fibrinogen - powder and solvent for solution for infusion - 1.5gram

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

icu medical inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - intravenous solutions containing dextrose and sodium chloride are indicated for parenteral replenishment of fluid, minimal carbohydrate calories, and sodium chloride as required by the clinical condition of the patient. none known. to open: tear outer wrap at notch and remove solution container. if supplemental medication is desired, follow directions below before preparing for administration. to add medication - prepare additive port. - using aseptic technique and an additive delivery needle of appropriate length, puncture resealable additive port at target area, inner diaphragm and inject. withdraw needle after injecting medication. - the additive port may be protected by covering with an additive cap. - mix container contents thoroughly. preparation for administration (use aseptic technique) - close flow control clamp of administration set. - remove cover from outlet port at bottom of container. - insert piercing pin of administration set into port with a twisting motion until the set is firmly seated. note: when using a vented administration set, replace bacterial retentive air filter with piercing pin cover. insert piercing pin with twisting motion until shoulder of air filter housing rests against the outlet port flange. - suspend container from hanger. - squeeze and release drip chamber to establish proper fluid level in chamber. - attach venipuncture device to set. - open clamp to expel air from set and venipuncture device. close clamp. - perform venipuncture. - regulate rate of administration with flow control clamp. warning: do not use flexible container in series connections.

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

icu medical inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698) - this solution is indicated in patients requiring parenteral administration of potassium chloride with minimal carbohydrate calories. solutions containing potassium chloride are contraindicated in diseases where high potassium levels may be encountered. to open tear outer wrap at notch and remove solution container. if supplemental medication is desired, follow directions below before preparing for administration. some opacity of the plastic due to moisture absorption during the sterilization process may be observed. this is normal and does not affect the solution quality or safety. the opacity will diminish gradually. to add medication - prepare additive port. - using aseptic technique and an additive delivery needle of appropriate length, puncture resealable additive port at target area, inner diaphragm and inject. withdraw needle after injecting medication. - the additive port may be protected by covering with an additive cap. - mix container contents thoroughly. preparation for administration (use aseptic technique) - close flow control clamp of administration set. - remove cover from outlet port at bottom of container. - insert piercing pin of administration set into port with a twisting motion until the set is firmly seated. note: when using a vented administration set, replace bacterial retentive air filter with piercing pin cover. insert piercing pin with twisting motion until shoulder of air filter housing rests against the outlet port flange. - suspend container from hanger. - squeeze and release drip chamber to establish proper fluid level in chamber. - attach venipuncture device to set. - open clamp to expel air from set and venipuncture device. close clamp. - perform venipuncture. - regulate rate of administration with flow control clamp. warning: do not use flexible container in series connections.

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

mk laboratory - lidocaine 2% w/v. purpose: topical analgesic, tetracaine 1% w/v. purpose: topical analgesic, witch hazel 30% w/v. purpose: astringent - lidocaine 2% w/v. purpose: topical analgesic tetracaine 1% w/v. purpose: topical analgesic witch hazel 30% w/v. purpose: astringent - for temporary relief of pain during tattoo and piercing procedures. - reduce sensitivity, inflammation, and redness during tattoo and piercing aftercare do not use more than 30 ml in a 6 hour period. - stop use and contact doctor if skin irritations occur. if irritation, rinse thoroughly with water. - if swallowed, get medical help or contact poison control center. 1-800-222-1222